Treatment intensification in patients with type 2 diabetes who failed metformin monotherapy

No abstract is available for this paper.

• Publication year

  2011

• Venue

  Diabetes, obesity and metabolism

• Publication date

  2011-08-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1111/j.1463-1326.2011.01405.xPMID 21457427
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Clinical inertia in management of T2DM.

  2010cited by this paper
• Clinical inertia in general practice: widespread and related to the outcome of diabetes care.

  2009cited by this paper
• Medical Management of Hyperglycemia in Type 2 Diabetes: A Consensus Algorithm for the Initiation and Adjustment of Therapy

  2009cited by this paper
• Sustained Hyperglycemia Among Patients With Diabetes

  2009cited by this paper
• Trends in medication use among US adults with diabetes mellitus: glycemic control at the expense of controlling cardiovascular risk factors.

  2009cited by this paper
• Diabetes prevalence and therapeutic target achievement in the United States, 1999 to 2006.

  2009cited by this paper
• Factors Associated With Intensification of Oral Diabetes Medications in Primary Care Provider-Patient Dyads: A Cohort Study

  2009cited by this paper
• Predictors and Impact of Intensification of Antihyperglycemic Therapy in Type 2 Diabetes

  2009cited by this paper
• Medical Management of Hyperglycemia in Type 2 Diabetes: A Consensus Algorithm for the Initiation and Adjustment of Therapy: A Consensus Statement of the American Diabetes Association and the European Association for the Study of Diabetes

  2009influential reference
• Management of Hyperglycemia in Type 2 Diabetes: A Consensus Algorithm for the Initiation and Adjustment of Therapy: A Consensus Statement From the American Diabetes Association and the European Association for the Study of Diabetes

  2007cited by this paper
• PMC1 COMPARISON OF EMR DATA TO US NATIONAL DATA

  2007cited by this paper
• Therapy Modifications in Response to Poorly Controlled Hypertension, Dyslipidemia, and Diabetes Mellitus

  2006cited by this paper
• Management of Hyperglycemia in Type 2 Diabetes: A Consensus Algorithm for the Initiation and Adjustment of Therapy

  2006cited by this paper
• Developing a quality measure for clinical inertia in diabetes care.

  2005cited by this paper
• The burden of treatment failure in type 2 diabetes.

  2004cited by this paper
• Slow response to loss of glycemic control in type 2 diabetes mellitus.

  2003cited by this paper
• Clinical inertia.

  2002cited by this paper
• Clinical Inertia

  2001cited by this paper

• Characterization of Treatment Intensified (Add-on to Metformin) Adults with Type 2 Diabetes: Real-world Clinical Experience (Cardiovascular Outcomes and Value in the Real-world with Glucagon-like Peptide-1 Receptor Agonists) from India in 2008 to 2017

  2025cites this paper
• Therapeutic Inertia in the Management of Type 2 Diabetes: A Narrative Review

  2024cites this paper
• Wait Times for Scheduling Appointments for Prevention of Macrovascular and Microvascular Complications of Diabetes: Cross-Sectional Descriptive Study

  2024cites this paper
• Evaluating Therapeutic Inertia in Two Telehealth Interventions for Type 2 Diabetes: Secondary Analyses of a Randomized Trial

  2024cites this paper
• Type 2 diabetes progression in an adult Ugandan population with new-onset diabetes: an observational prospective study

  2023cites this paper
• Sex disparities in treatment patterns after metformin initiation among patients with type 2 diabetes mellitus

  2023cites this paper
• Addressing Therapeutic Inertia: Development and Implementation of an Electronic Health Record–Based Diabetes Intensification Tool

  2022cites this paper
• Trends in Timing of and Glycemia at Initiation of Second-line Type 2 Diabetes Treatment in U.S. Adults.

  2022cites this paper
• Conquering diabetes therapeutic inertia: practical tips for primary care

  2022cites this paper
• Treatment Patterns and Associated Clinical Outcomes in Type 2 Diabetes Patients Initiating Second-Line Glucose-Lowering Therapy: Interim Analysis of Baseline Data from Turkey Arm of the Global DISCOVER Study

  2021cites this paper
• Therapeutic inertia in patients with type 2 diabetes treated with non-insulin agents.

  2021cites this paper
• Why Are We Stuck? Therapeutic Inertia in Diabetes Education

  2020cites this paper
• Addressing Therapeutic Inertia in 2020 and Beyond: A 3-Year Initiative of the American Diabetes Association

  2020cites this paper
• Evaluating the Evidence behind the Novel Strategy of Early Combination from Vision to Implementation

  2020cites this paper
• An observational study of clinical inertia among patients with type 2 diabetes mellitus in a tertiary care hospital

  2020cites this paper
• Intensification patterns and the probability of HbA1c goal attainment in Type 2 diabetes mellitus: real‐world evidence for the concept of ‘intensification inertia’

  2020cites this paper
• Clinical inertia in type 2 diabetes management in a middle-income country: A retrospective cohort study

  2020cites this paper
• Distance to glycemic goal at the time of treatment intensification in patients with type 2 diabetes mellitus failing metformin monotherapy in the United States

  2020cites this paper
• Real-World Adequacy of Glycaemic Control in Treatment-Naïve Greek Patients with Type 2 Diabetes Mellitus Initiating Treatment with Metformin Monotherapy at the Maximum Tolerated Dose: The Reload Study.

  2020cites this paper
• The impact of phenotype, ethnicity and genotype on progression of type 2 diabetes mellitus

  2020cites this paper
• Clinical inertia is the enemy of therapeutic success in the management of diabetes and its complications: a narrative literature review

  2020cites this paper
• Performance of a computable phenotype for identification of patients with diabetes within PCORnet: The Patient‐Centered Clinical Research Network

  2019influential citation
• Combining GLP-1 Receptor Agonists and Basal Insulin in Older Adults with Type 2 Diabetes: Focus on Lixisenatide and Insulin Glargine

  2019cites this paper
• Delays in anti‐hyperglycaemic therapy initiation and intensification are associated with cardiovascular events, hospitalizations for heart failure and all‐cause mortality

  2019cites this paper
• Factors Associated with Diabetes-Related Clinical Inertia in a Managed Care Population and Its Effect on Hemoglobin A1c Goal Attainment: A Claims-Based Analysis.

  2019cites this paper
• Time to Treatment Intensification in Newly Treated Adult Type 2 Diabetes Patients: Comparison of Canada and the United States.

  2019cites this paper
• Effect of DPP-IV Inhibitors on Glycemic Variability in Patients with T2DM: A Systematic Review and Meta-Analysis

  2019cites this paper
• Therapeutic inertia in type 2 diabetes: prevalence, causes, consequences and methods to overcome inertia

  2019cites this paper
• Evaluation of the Therapeutic Approach and Outcome of Type 2 Diabetes Mellitus Management Strategies in Cameroon

  2019cites this paper
• Factors associated with clinical inertia in type 2 diabetes mellitus patients treated with metformin monotherapy

  2019cites this paper
• Time to Treatment Intensification After Monotherapy Failure and Its Association With Subsequent Glycemic Control Among 93,515 Patients With Type 2 Diabetes

  2018cites this paper
• Therapeutic inertia in patients treated with two or more antidiabetics in primary care: Factors predicting intensification of treatment

  2018cites this paper
• Ertugliflozin and Sitagliptin Co-initiation in Patients with Type 2 Diabetes: The VERTIS SITA Randomized Study

  2018cites this paper
• Efficacy and Safety of Initial Combination Therapy in Treatment-Naïve Type 2 Diabetes Patients: A Systematic Review and Meta-analysis

  2018cites this paper
• Impact of Timely Treatment Intensification on Glycemic Goal Achievement in Patients With Type 2 Diabetes Failing Metformin Monotherapy

  2017cites this paper
• Patterns of glycaemic control in patients with type 2 diabetes mellitus initiating second‐line therapy after metformin monotherapy: Retrospective data for 10 256 individuals from the United Kingdom and Germany

  2017cites this paper
• Patient and Provider Factors Affecting Clinical Inertia in Patients With Type 2 Diabetes on Metformin Monotherapy.

  2017cites this paper
• Diabetes Research and Care Through the Ages

  2017cites this paper
• Beyond oral antidiabetics: Insulin therapy options and combinations

  2017cites this paper
• Change in HbA1c associated with treatment intensification among patients with type 2 diabetes and poor glycemic control

  2017cites this paper
• Therapeutic inertia in the treatment of hyperglycaemia in patients with type 2 diabetes: A systematic review

  2017cites this paper
• Sodium-glucose cotransporter 2 inhibitors combined with dipeptidyl peptidase-4 inhibitors in the management of type 2 diabetes: a review of current clinical evidence and rationale

  2017cites this paper
• Causas de descontrol metabólico en atención primaria

  2016cites this paper
• Consequences of delaying treatment intensification in type 2 diabetes: evidence from a UK database

  2016cites this paper
• Treatment of Type 2 Diabetes: From “Guidelines” to “Position Statements” and Back

  2016cites this paper
• Clinical Considerations for Use of Initial Combination Therapy in Type 2 Diabetes

  2016cites this paper
• Patient‐level predictors of achieving early glycaemic control in Type 2 diabetes mellitus: a population‐based study

  2016cites this paper
• Use of Add-on Treatment to Metformin Monotherapy for Patients with Type 2 Diabetes and Suboptimal Glycemic Control: A U.S. Database Study

  2016influential citation
• Intensification of Diabetes Therapy and Time Until A1C Goal Attainment Among Patients With Newly Diagnosed Type 2 Diabetes Who Fail Metformin Monotherapy Within a Large Integrated Health System

  2016influential citation
• Combination therapy for type 2 diabetes: dapagliflozin plus metformin

  2016cites this paper
• [Poor metabolic control in primary care].

  2016cites this paper
• DOES CLINICAL INERTIA VARY BY PERSONALIZED A1C GOAL? A STUDY OF PREDICTORS AND PREVALENCE OF CLINICAL INERTIA IN A U.S. MANAGED CARE SETTING.

  2016cites this paper
• Clinical and Economic Outcomes Associated With the Timing of Initiation of Basal Insulin in Patients With Type 2 Diabetes Mellitus Previously Treated With Oral Antidiabetes Drugs.

  2016cites this paper
• Treatment intensification for patients with type 2 diabetes and poor glycaemic control

  2016cites this paper
• The individual contribution and relative importance of self-management and quality of care on glycaemic control in type 2 diabetes.

  2016cites this paper
• CUMPLIMIENTO E INERCIA TERAPÉUTICA EN LA DIABETES MELLITUS TIPO 2 El problema de la inercia terapéutica en el tratamiento de la diabetes mellitus tipo 2 en España

  2016cites this paper
• Reasons for non-intensification of treatment in people with type 2 diabetes receiving oral monotherapy: Outcomes from the prospective DIAttitude study.

  2016cites this paper
• DOES CLINICAL INERTIA VARY BY PERSONALIZED A1C GOAL? A STUDY OF PREDICTORS AND PREVALENCE OF CLINICAL INERTIA IN A U.S. MANAGED-CARE SETTING.

  2015cites this paper
• Antidiabetic Treatment Patterns in a Medicare Advantage Population in the United States

  2015cites this paper
• A Real-World Observational Study of Time to Treatment Intensification Among Elderly Patients with Inadequately Controlled Type 2 Diabetes Mellitus.

  2015cites this paper
• Provider behavior and treatment intensification in diabetes care.

  2015cites this paper
• Pharmacogenetics and individual responses to treatment of hyperglycemia in type 2 diabetes.

  2015cites this paper
• Changing trends in type 2 diabetes mellitus treatment intensification, 2002-2010.

  2015cites this paper
• Adherence to treatment guidelines in Type 2 diabetes patients failing metformin monotherapy in a real-world setting

  2015cites this paper
• Clinical inertia in the management of type 2 diabetes mellitus: a focused literature review

  2015cites this paper
• Instauration d'une insulinothérapie chez les patients diabétiques de type 2 : enquête de pratiques chez les médecins généralistes installés en Corse

  2014cites this paper
• Causas de descontrol metabólico en pacientes con diabetes en atención primaria en el Instituto Mexicano del Seguro Social (IMSS)

  2014cites this paper
• Impact of time to treatment intensification on glycemic goal attainment among patients with type 2 diabetes failing metformin monotherapy.

  2014cites this paper
• Intensification of antihyperglycemic therapy among patients with incident diabetes: a Surveillance Prevention and Management of Diabetes Mellitus (SUPREME‐DM) study

  2014cites this paper
• [Causes of insufficient effectiveness of diabetes treatment at primary care units, of the Instituto Mexicano del Seguro Social (IMSS)].

  2014cites this paper
• A nomogram to estimate the proportion of patients at hemoglobin A1c target <7% with noninsulin antidiabetic drugs in type 2 diabetes: a systematic review of 137 randomized controlled trials with 39 845 patients

  2014cites this paper
• Instauration d'une insulinothérapie chez les patients diabétiques de type 2 : enquête de pratiques chez les médecins généralistes installés en Corse

  2014cites this paper
• The individual contribution and relative importance of self-management and quality of care on glycaemic control in Mexican patients with type 2 diabetes

  2013cites this paper
• Combine and conquer: advantages and disadvantages of fixed‐dose combination therapy

  2013cites this paper
• Assessment of AACE/ACE recommendations for initial dual antihyperglycemic therapy using the fixed-dose combination of sitagliptin and metformin versus metformin.

  2013cites this paper
• El problema de la inercia terapéutica en el tratamiento de la diabetes mellitus tipo 2 en España

  2012cites this paper
• Therapeutic management of orally treated type 2 diabetic patients , by French general practitioners in 2010 : the DIAttitude Study

  2012cites this paper
• Therapeutic management of orally treated type 2 diabetic patients, by French general practitioners in 2010: the DIAttitude Study.

  2012cites this paper
• Study of Once Daily Levemir (SOLVE™): insights into the timing of insulin initiation in people with poorly controlled type 2 diabetes in routine clinical practice

  2012cites this paper
• Type 2 diabetes treatment intensification in general practice in France in 2008-2009: the DIAttitude Study.

  2012cites this paper
• Use of the dipeptidyl peptidase-4 inhibitor linagliptin in combination therapy for type 2 diabetes

  2012cites this paper
• A look into the future: improving diabetes care by 2015

  2011cites this paper